Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients.

52W Range

2ndpctl

Volume

0.48×avg

Market Cap

44.80MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Metagenomi, Inc. Common Stock

MGXNASDAQ Global Select·USD·Closed

Metagenomi, Inc. Common Stock

MGXNASDAQ·USD·Closed

$1.19

−1.65%

$1.19

−$0.02 (1.65%)

52W Range

2ndpctl

Volume

0.48×avg

Mkt Cap

44.80MUSD

P/E

-0.5TTM

Div Yield

–ann

MGX: Metagenomi, Inc. Common Stock Stock Analysis | finqOS